Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$100.62
+2.14%
Mkt Cap $6.74B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $8.74M | $7.44M | -14.92% | -$0.53 | -$0.69 | -30.19% | — | — |
| Q4 2025 Nov 6, 2025 | $14.92M | $4.71M | -68.41% | -$0.59 | -$0.62 | -5.08% | — | — |
| Q3 2025 Aug 6, 2025 | $8.43M | $5.55M | -34.20% | -$0.53 | -$0.55 | -3.77% | — | — |
| Q2 2025 May 6, 2025 | $6.56M | $28.32M | +332.01% | -$0.50 | -$0.19 | +62.00% | — | — |
| Q1 2025 Feb 21, 2025 | $81.01M | $170.64M | +110.63% | $0.06 | $1.98 | +3200.00% | — | — |
| Q4 2024 Nov 7, 2024 | $38.81M | $4.67M | -87.95% | -$0.59 | -$0.54 | +8.47% | — | — |
| Q3 2024 Aug 6, 2024 | $8.00M | $4.17M | -47.91% | -$0.50 | -$0.50 | +0.00% | — | — |
| Q2 2024 May 7, 2024 | $120.00M | $254.95M | +112.46% | $1.19 | $3.26 | +173.95% | — | — |
| Q1 2024 Feb 27, 2024 | $40.00M | $60.00M | +50.00% | $0.03 | $0.44 | +1425.13% | — | — |
| Q4 2023 Nov 2, 2023 | $38.33M | — | — | -$0.68 | -$0.58 | +14.71% | — | — |
| Q3 2023 Aug 3, 2023 | $8.33M | — | — | -$0.65 | -$0.68 | -4.62% | — | — |
| Q2 2023 May 4, 2023 | $2.00M | — | — | -$0.69 | -$0.67 | +2.90% | — | — |
| Q1 2023 Mar 15, 2023 | $5.00M | — | — | -$0.67 | -$0.69 | -2.99% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.94 | -$0.64 | +31.91% | — | — |
| Q3 2022 Aug 4, 2022 | $460.00K | $859.00K | +86.74% | -$0.99 | -$0.84 | +15.15% | — | — |
| Q2 2022 May 4, 2022 | $21.18M | $25.72M | +21.43% | -$0.67 | -$0.43 | +35.82% | — | — |
| Q1 2022 Feb 28, 2022 | $5.07M | $8.62M | +69.91% | -$0.79 | -$0.77 | +2.53% | — | — |
| Q4 2021 Nov 3, 2021 | $2.03M | $10.29M | +406.70% | -$0.67 | -$0.70 | -4.48% | — | — |
| Q3 2021 Aug 4, 2021 | $5.17M | $2.27M | -56.19% | -$0.62 | -$0.69 | -11.29% | — | — |
| Q2 2021 May 4, 2021 | $3.12M | $6.19M | +98.37% | -$0.57 | -$0.54 | +5.26% | — | — |